Evenity (Romosozumab) East Asian Safety Profile Differences
A clinical review of what is and is not known about romosozumab safety, efficacy, cardiovascular risk, and dosing in East Asian patients.
3 source-based articles maintained by the HealthRX.com Editorial Team.

Showing 3 of 3 clinical reviews.
A clinical review of what is and is not known about romosozumab safety, efficacy, cardiovascular risk, and dosing in East Asian patients.
Evidence-based review of romosozumab (Evenity) safety, efficacy, and pharmacogenomic considerations specific to Black and African ancestry patients, including cardiovascular risk data and dosing guidance.
Evidence-based review of romosozumab efficacy in South Asian populations, including pharmacogenomic factors, dosing considerations, bone density response data, and cardiovascular risk context.